Načítá se...
Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study
OBJECTIVE: Oral once-daily dual-release hydrocortisone (DR-HC) replacement therapy was developed to provide a cortisol exposure−time profile that closely resembles the physiological cortisol profile. This study aimed to characterize single-dose pharmacokinetics (PK) of DR-HC 5–20mg and assess intras...
Uloženo v:
| Vydáno v: | Eur J Endocrinol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bioscientifica Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5065076/ https://ncbi.nlm.nih.gov/pubmed/27129362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-1212 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|